Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis - European Thyroid Association Recommends Tiratricol (Emcitate) In New Guidelines

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    17/07/2024 07:54
    July 17 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * EUROPEAN THYROID ASSOCIATION RECOMMENDS TIRATRICOL
(EMCITATE) AS
LONG-TERM THERAPY FOR ALL PATIENTS WITH MCT8 DEFICIENCY IN NEW
GUIDELINES

Source text for Eikon:  ID:nMFNNtY4m 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news